ENTITY
Pfizer Inc

Pfizer Inc (PFE US)

289
Analysis
Health CareUnited States
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
more
Refresh
08 Feb 2017 09:38

If Reckitt Benckiser Buys Mead Johnson Then Is a Home Care Spinoff Next?

Reckitt Benckiser Group (RB) is currently in “advanced” talks to buy Mead Johnson Nutrition Co for USD16.7 billion, in a deal that makes little...

Share
30 Jan 2017 13:50

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at...

bearishCelltrion Inc
20 Jan 2017 20:59

Recent Developments Not Encouraging

This Insight provides an update on developments in the US market related to biosimilars, and are of great significance to Celltrion Inc (068270...

Share
15 Jan 2017 19:34

Cybercriminals and Activists Scale up Their Attacks – Who's at Risk and Why?

Distributed denial of service (DDoS) attacks have significantly increased in size, carried out by threat actors exploiting internet of things (IoT)...

Logo
305 Views
Share
bullishDaiichi Sankyo
03 Jan 2017 13:30

Quizartinib: FMS–like Tyrosine Kinase 3 (FLT 3) Inhibitor

Acute Myeloid Leukemia (AML) represents one of the largest hematologic cancer populations with one of the worst survival rates. Patients with r/r...

x